Viewing Study NCT05147558

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:00 AM
Ignite Modification Date: 2026-01-25 @ 5:05 AM
Study NCT ID: NCT05147558
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-26
First Post: 2021-11-15
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of Pembrolizumab With Lenvatinib in Women With Advanced Uterine Carcinosarcoma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Uterine Carcinosarcoma View
None Advanced Uterine Carcinosarcoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pembrolizumab View
None Lenvatinib View
None 21-273 View